Tempus AI, Inc. (TEM)
65.47
-5.66
(-7.96%)
USD |
NASDAQ |
Oct 16, 14:10
Tempus AI SG&A Expense (TTM) : 834.84M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 834.84M |
| March 31, 2026 | 789.70M |
| December 31, 2025 | 731.74M |
| September 30, 2025 | 634.52M |
| June 30, 2025 | 548.05M |
| March 31, 2025 | 830.41M |
| December 31, 2024 | 755.35M |
| September 30, 2024 | 644.06M |
| June 30, 2024 | 542.64M |
| March 31, 2024 | 79.56M |
| Date | Value |
|---|---|
| December 31, 2023 | 69.05M |
| September 30, 2023 | 133.48M |
| June 30, 2023 | 188.33M |
| March 31, 2023 | 238.59M |
| December 31, 2022 | 212.43M |
| December 31, 2021 | 178.94M |
| September 30, 2021 | 124.09M |
| December 31, 2020 | 73.83M |
| September 30, 2020 | 30.95M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Personalis, Inc. | 67.03M |
| 10X Genomics, Inc. | 297.01M |
| Twist Bioscience Corp. | 290.29M |
| Moderna, Inc. | 965.00M |
| IQVIA Holdings, Inc. | 2.058B |